JS
Insider
John G Stratton
DirectorJohn G Stratton (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales, 1 filed past the two-business-day deadline), most often in Abbott Laboratories (ABT). Across 1 priced purchase filing, the average 21-session return was +5.5% from execution and +15.5% from disclosure (delay-adjusted; derived). The largest single filing was $174K of ABT (2,000 sh × $86.82, as filed), executed May 7.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+5.5%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+15.5%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells · 1 late
Median delay
42d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$174K
shares × price, as filed
Last traded
May 7
Filed Jun 18
Median ADV $1.4B across their filed names
Open performance→Volume by month
Buys $174K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ABTRecent filings
ABTPURCHASE
Abbott Laboratories
View filing →
$174K2,000 sh × $86.82
Exec May 7
Filed Jun 18 · 5:08 PM ET †